Form 4 for CABR Caring Brands, Inc.
Accepted 2026-03-27 00:00:00 ET · period of report 2026-03-27 · accession 0001493152-26-013341 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | 2026-03-27 | CABR | WILSON GLYNN | CEO, Dir | D - Sale to Iss | $0.5 | -1.50M | 672.6K | -69% | -$750.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-27 | D | D | 1,500,000 | $0.5 | 672,592 | D | — | — | (F2) The number of shares of common stock beneficially owned following the reported transaction includes Dr. Wilson's ownership of (i) 126,720 restricted stock units of common stock of the Issuer of which zero have vested, (ii) 45,872 restricted stock units of common stock of the Issuer of which zero have vested, and (iii) 500,000 shares of common stock. |